The company is increasing the credit line of MyMedicalRecords Inc. by USD1.5m, to a total of USD4.5m.
The increased credit facility will help in the sales and marketing of the MyMedicalRecords patented Personal Health Record and MMRPro professional products and services, and continue ongoing talks with potential strategic partners to add to and exploit its biotech range.
Perrigo to acquire United States rights for Entocort from AstraZeneca
US FDA approves Boehringer Ingelheim's Pradaxa
Phase II clinical trial for potential treatment of androgenetic alopecia completed by Samumed
Life Sciences Partners collaborates on immuno-oncology with Bristol-Myers Squibb
Arsanis initiates first cohort in Phase one clinical trial of ASN100
Impax introduces generic Avodart (Dutasteride) Capsules, 0.5 mg
Mylan unveils generic FazaClo orally disintegrating tablets for treating schizophrenia